首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >The Effect of Dongeui Qigong for Prehypertension and Mild Essential Hypertension
【2h】

The Effect of Dongeui Qigong for Prehypertension and Mild Essential Hypertension

机译:东瑞气功对高血压前期和轻度原发性高血压的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although several previous studies have reported the effect of qigong on lowering blood pressure, rigorous trials are lacking. Studies evaluating the effect of qigong on prehypertension are also scarce. This study aimed to assess the effect of qigong on prehypertension and mild hypertension. Participants with prehypertension or mild hypertension were randomized to the Dongeui qigong group or a nontreated control group. In the qigong group, Dongeui qigong was administered 5 times/week for 12 weeks. The control group did not receive any intervention for blood pressure control. Fifty-two participants were included in this study. Even though diastolic blood pressure was significantly reduced in the qigong group after 8 weeks (p = 0.04) compared to baseline, the difference in change in blood pressure between the qigong and control groups was not significant. There were no significant differences in quality of life between the qigong and control groups. Dongeui qigong is not significantly effective in pre/mild hypertension compared with controls. This result could be due to a lack of effect of qigong or caused by other factors, such as the type of qigong, target symptoms, inappropriate sample size, and compliance of participants. Trial Registration. This trial is registered with (Clinical Research Information Service).
机译:尽管先前的一些研究已经报道了气功对降低血压的作用,但仍缺乏严格的试验。评估气功对高血压前期影响的研究也很少。本研究旨在评估气功对高血压前期和轻度高血压的影响。患有高血压前期或轻度高血压的参与者被随机分配到东瑞气功组或未经治疗的对照组。气功组每周进行5次,每周12次,共5次。对照组未接受任何血压控制干预。本研究包括52名参与者。尽管与基线相比,气功组在8周后舒张压显着降低(p = 0.04),但气功组与对照组之间的血压变化差异并不显着。气功组和对照组之间的生活质量没有显着差异。与对照组相比,冬果气功对高血压前期/轻度患者无效。此结果可能是由于缺乏气功效果或其他因素引起的,例如气功的类型,目标症状,不适当的样本量以及参与者的依从性。试用注册。该试验已向(临床研究信息服务)注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号